Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

5.8K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.1K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.7K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.7K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inducible CRISPRi enables efficient and high-fidelity genome editing in Streptomyces.

Nucleic acids research·2026
Same author

COMMBAT: a web platform for exploring expression control of biosynthetic gene clusters.

Nucleic acids research·2026
Same author

PARAS: High-Accuracy Machine Learning of Substrate Specificities in Nonribosomal Peptide Synthetases.

JACS Au·2026
Same author

Facultative predation expands the ecological repertoire of <i>Streptomyces</i>.

mBio·2026
Same author

Morphological plasticity of endophytic Chitinophaga pinensis.

Antonie van Leeuwenhoek·2026
Same author

Plant Coumarins Modulate Natural Product Biosynthesis in a <i>Streptomyces</i> Root Endophyte.

Journal of natural products·2026

Related Experiment Video

Updated: Oct 8, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.5K

Anthracyclines: biosynthesis, engineering and clinical applications.

Mandy B Hulst1, Thadee Grocholski2, Jacques J C Neefjes3

  • 1Institute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands. g.wezel@biology.leidenuniv.nl.

Natural Product Reports
|December 24, 2021
PubMed
Summary

New anthracyclines targeting histone eviction offer a cardiotoxicity-free alternative to doxorubicin. Advances in biosynthesis and discovery pave the way for next-generation cancer chemotherapy agents.

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K

Related Experiment Videos

Last Updated: Oct 8, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.5K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K

Area of Science:

  • Natural Product Chemistry
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Anthracyclines are potent antiproliferative natural products with anticancer activity.
  • Doxorubicin, a widely used anthracycline, is limited by severe cardiotoxicity.
  • Recent research links cardiotoxicity to topoisomerase II poisoning, suggesting alternative mechanisms.

Purpose of the Study:

  • To explore anthracycline mechanisms of action beyond DNA double-strand breaks.
  • To investigate histone eviction as a strategy for developing cardiotoxicity-free anticancer agents.
  • To review advances in anthracycline biosynthesis and discovery for novel drug development.

Main Methods:

  • Review of recent studies on anthracycline mode-of-action.
  • Analysis of metabolic engineering and combinatorial biosynthesis approaches.
  • Exploration of novel congener discovery from rare Actinobacteria.

Main Results:

  • Histone eviction activity is identified as a promising target for cardiotoxicity-free anthracyclines.
  • Metabolic engineering and combinatorial biosynthesis enable generation of novel compound libraries.
  • Improved understanding of *Streptomyces* biology and production enhances anthracycline development.

Conclusions:

  • Targeting histone eviction offers a path to safer and more effective anthracycline-based cancer therapies.
  • Advances in biosynthesis and discovery are crucial for developing next-generation anthracyclines.
  • Novel anthracyclines have the potential to overcome limitations of current treatments like doxorubicin.